XPRIZE Healthspan names 20 finalists
Ten teams receive $1m awards as the $101m competition moves from therapeutic promise towards coordinated human trials. XPRIZE Healthspan has selected 20 finalists to advance to the clinical phase of its seven-year, $101 million competition, with ten teams receiving $1 million Milestone 2 awards to s

<p>Ten teams receive $1m awards as the $101m competition moves from therapeutic promise towards coordinated human trials. XPRIZE Healthspan has selected 20 finalists to advance to the clinical phase of its seven-year, $101 million competition, with ten teams receiving $1 million Milestone 2 awards to s</p>